Cargando…

Drug-induced hepatitis and the risk factors for liver injury in pulmonary tuberculosis patients

INTRODUCTION: Short-course chemotherapy containing rifampicin and isoniazid in combination has proved to be highly effective in the treatment of tuberculosis, but one of its adverse effects is hepatotoxicity. Various risk factors have been found to be associated with drug-induced liver injury (DILI)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gaude, Gajanan S., Chaudhury, Alisha, Hattiholi, Jyothi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4408708/ https://www.ncbi.nlm.nih.gov/pubmed/25949974 http://dx.doi.org/10.4103/2249-4863.154661

Ejemplares similares

Role of Health Education and Self-Action Plan in Improving the Drug Compliance in Bronchial Asthma
por: Gaude, Gajanan S., et al.
Publicado: (2014)

Outcomes associated with acute exacerbations of chronic obstructive pulmonary disorder requiring hospitalization
por: Gaude, Gajanan S, et al.
Publicado: (2015)

Effects of oral montelukast on airway function in acute asthma: A randomized trial
por: Chaudhury, Alisha, et al.
Publicado: (2017)

Prevalence and correlates of osteoporosis in chronic obstructive pulmonary disease patients in India
por: Hattiholi, Jyothi, et al.
Publicado: (2014)

Bone mineral density among elderly patients with chronic obstructive pulmonary disease patients in India
por: Hattiholi, Jyothi, et al.
Publicado: (2013)

Risk factors and drug-resistance patterns among pulmonary tuberculosis patients in northern Karnataka region, India
por: Gaude, Gajanan S., et al.
Publicado: (2014)

Primary neuroendocrine carcinoma of the thymus
por: Gaude, Gajanan S., et al.
Publicado: (2013)

Pulmonary manifestations of gastroesophageal reflux disease
por: Gaude, Gajanan S.
Publicado: (2009)

Hepatitis C and not Hepatitis B virus is a risk factor for anti-tuberculosis drug induced liver injury
por: Kim, Wan Soo, et al.
Publicado: (2016)

An Investigation of the Risk Factors Associated With Anti-Tuberculosis Drug-Induced Liver Injury or Abnormal Liver Functioning in 757 Patients With Pulmonary Tuberculosis
por: Zhong, Tao, et al.
Publicado: (2021)

Predictors of mortality in acute exacerbations of chronic obstructive pulmonary disease using the dyspnea, eosinopenia, consolidation, acidemia and atrial fibrillation score
por: Bansal, Avya Gopal, et al.
Publicado: (2020)

TUBERCULOSIS OF THE CHEST WALL WITHOUT PULMONARY INVOLVEMENT
por: Gaude, G.S., et al.
Publicado: (2008)

Risk factors for acute liver failure among inpatients with anti-tuberculosis drug-induced liver injury
por: Wang, Shuting, et al.
Publicado: (2018)

Anti-tuberculosis drug-induced liver injury in patient with hepatitis B and cirrhosis: A case report
por: Aminy, Rusdi Zakki, et al.
Publicado: (2022)

Primary mediastinal choriocarcinoma
por: Gaude, Gajanan S., et al.
Publicado: (2013)

Hepatitis C Virus Co-Infection Increases the Risk of Anti-Tuberculosis Drug-Induced Hepatotoxicity among Patients with Pulmonary Tuberculosis
por: Lomtadze, Nino, et al.
Publicado: (2013)

Critical illness myopathy and polyneuropathy - A challenge for physiotherapists in the intensive care units
por: Pattanshetty, Renu B., et al.
Publicado: (2011)

The role of hepatitis B infection in anti-tuberculosis drug-induced liver injury: a meta-analysis of cohort studies
por: Zheng, Jing, et al.
Publicado: (2020)

Clinical characteristics of drug-induced liver injury and related risk factors
por: Lu, Ren-Jie, et al.
Publicado: (2016)

Does diabetes mellitus comorbidity increase the risk of drug-induced liver injury during tuberculosis treatment?
por: D. Freire, Ivanice, et al.
Publicado: (2023)

Protective Effect of Bicyclol on Anti-Tuberculosis Drug Induced Liver Injury in Rats
por: Liu, Xin, et al.
Publicado: (2017)

Case Characterization, Clinical Features and Risk Factors in Drug-Induced Liver Injury
por: Ortega-Alonso, Aida, et al.
Publicado: (2016)

Pharmacogenetic Study of Drug-Metabolising Enzyme Polymorphisms on the Risk of Anti-Tuberculosis Drug-Induced Liver Injury: A Meta-Analysis
por: Cai, Yu, et al.
Publicado: (2012)

A nomogram model to predict the risk of drug-induced liver injury in patients receiving anti-tuberculosis treatment
por: Ji, Songjun, et al.
Publicado: (2023)

Effect of sevoflurane pretreatment in relieving liver ischemia/reperfusion-induced pulmonary and hepatic injury
por: Xu, Guiping, et al.
Publicado: (2019)

Abundance of Cytochromes in Hepatic Extracellular Vesicles Is Altered by Drugs Related With Drug‐Induced Liver Injury
por: Palomo, Laura, et al.
Publicado: (2018)

Plasma metabolomic and lipidomic alterations associated with anti-tuberculosis drug-induced liver injury
por: Wang, Ming-Gui, et al.
Publicado: (2022)

Factors affecting drug-induced liver injury: antithyroid drugs as instances
por: Heidari, Reza, et al.
Publicado: (2014)

Time of Liver Function Abnormal Identification on Prediction of the Risk of Anti-tuberculosis-induced Liver Injury
por: Huang, Deliang, et al.
Publicado: (2023)

Association of UGT2B7 polymorphisms with risk of induced liver injury by anti-tuberculosis drugs in Chinese Han
por: Chen, Guo, et al.
Publicado: (2017)

Hepatitis E Virus Detection in Liver Tissue from Patients with Suspected Drug-Induced Liver Injury
por: Chijioke, Obinna, et al.
Publicado: (2015)

Clinical and Genetic Risk Factors for Drug-Induced Liver Injury Associated with Anti-Tuberculosis Treatment—A Study from Patients of Portuguese Health Centers
por: Cavaco, Maria João, et al.
Publicado: (2022)

Rifampicin: Drug-induced liver injury leading to acute liver failure and hepatic encephalopathy: case report
Publicado: (2020)

The risk of pulmonary tuberculosis after traumatic brain injury
por: Liu, Hsin-Yueh, et al.
Publicado: (2021)

Drug-Induced Liver Injury
por: Almario, Eileen E. N., et al.
Publicado: (2017)

Drug-induced liver injury
por: Suh, Jeong Ill
Publicado: (2019)

Drug-induced liver injury
por: Kumachev, Alexander, et al.
Publicado: (2021)

Incidence, Clinical Features and Impact on Anti-Tuberculosis Treatment of Anti-Tuberculosis Drug Induced Liver Injury (ATLI) in China
por: Shang, Penghui, et al.
Publicado: (2011)

Acute Liver Injury in a Patient with Alcohol Dependence: A Case Resembling Autoimmune Hepatitis or Drug-Induced Liver Injury
por: Hayashi, Masahiro, et al.
Publicado: (2014)

Development of a prediction system for anti-tuberculosis drug-induced liver injury in Japanese patients
por: Mushiroda, Taisei, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_sjke87re7pgp8fd22jl749h9j1